Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Fondaparinux sodium bulk supplier for pharma manufacturers

Fondaparinux Sodium Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2.5 mg/0.5 mL, 5 mg/0.4 mL, 7.5 mg/0.6 mL, 10 mg/0.8 mL

Reference Brands: Arixtra (USA)

Category: Critical Care

Fondaparinux is a synthetic anticoagulant that inhibits factor Xa, an essential enzyme in the blood clotting process. It is used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE) and to prevent blood clots after major orthopedic or abdominal surgery.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Fondaparinux Sodium — third party manufacturing & bulk supply

Fondaparinux Sodium is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Fondaparinux Sodium listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Fondaparinux Sodium →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Fondaparinux sodium is used to prevent and treat blood clots in conditions such as deep vein thrombosis and pulmonary embolism, particularly after orthopedic or abdominal surgery.

Fondaparinux sodium is made from a synthetic pentasaccharide that selectively inhibits activated Factor Xa, preventing clot formation.

Trade names include Arixtra and Idraparinux (investigational).

Fondaparinux sodium is manufactured by Aspen Pharmacare, Mylan, and originally developed by GlaxoSmithKline under the brand name Arixtra.

The generic name is Fondaparinux sodium.

The brand name is Arixtra.

Fondaparinux sodium is manufactured in countries such as the United States, India, and the United Kingdom by several pharmaceutical companies for both hospital and retail use.

Related Products

Ringer's Lactate

Strength:
100 mL, 250 mL, 500 mL, 1000ml

Form: Infusion

Reference Brands: Generic formulations marketed under different names

View Details
Rolapitant Hydrochlorid

Strength:
90 mg

Form: Tablets

Reference Brands: Varubi(USA/LATAM), Varuby(EU)

View Details
Conivaptan Hydrochloride

Strength:
20 mg/100 mL

Form: Infusion

Reference Brands: Vaprisol (USA)

View Details
Fitusiran

Strength:
50 mg/0.5 ml, 20 mg/0.2ml

Form: injection (prefilled syringe)

Reference Brands: Generic formulations marketed under different names

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.